Jynarque 60MG/30MG
Ended Awarded
- Contract number
- 36C24523N0225
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,414
Award facts
- Contract value 100% obligated
- $11,413.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $11,413.72 delivery order to Otsuka America Pharmaceutical Inc. for Jynarque 60mg/30mg on December 8, 2022, with completion targeted for December 12, 2022. This firm-fixed-price delivery order was issued without a set-aside designation and is sourced under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Jynarque (tolvaptan) is a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia in veteran populations.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s larger Blanket Purchase Agreement with the VA's National Acquisition Center, valued at $83.3 million through March 26, 2026, which enables VA facilities across multiple Integrated Service Networks to procure Jynarque efficiently. The vendor, headquartered in Rockville, Maryland, is an established federal contractor with a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology products, and has a consistent track record supplying specialized medications to the VA's Veterans Health Administration across multiple regional networks.
Quick answers
Who was awarded contract 36C24523N0225?
36C24523N0225 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on December 8, 2022.
How much is contract 36C24523N0225 worth?
The government has obligated $11,414 on 36C24523N0225.
Is contract 36C24523N0225 an order under another contract?
Yes. 36C24523N0225 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0225 competed?
The extent of competition for 36C24523N0225 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award